|
Statement of Operations (USD $)
|
3 Months Ended | 9 Months Ended | 138 Months Ended | ||
|---|---|---|---|---|---|
|
Sep. 30, 2012
|
Sep. 30, 2011
|
Sep. 30, 2012
|
Sep. 30, 2011
|
Sep. 30, 2012
|
|
| Expenses: | |||||
| General and administrative | $ 600,242 | $ 774,307 | $ 2,071,008 | $ 2,811,097 | $ 29,418,003 |
| Research and development | 1,066,245 | 2,372,201 | 3,127,201 | 10,506,823 | 35,012,804 |
| Patent fees | 122,571 | 198,424 | 302,533 | 374,163 | 2,403,538 |
| Depreciation and amortization | 10,721 | 10,127 | 32,163 | 34,904 | 672,700 |
| Total Expenses | 1,799,779 | 3,355,059 | 5,532,905 | 13,726,987 | 67,507,045 |
| Loss from Operations | (1,799,779) | (3,355,059) | (5,532,905) | (13,726,987) | (67,507,045) |
| Other Income (Expense) | |||||
| Realized loss on marketable securities | 0 | (3,960) | (13,301) | ||
| Interest income | 6,641 | 19,592 | 17,184 | 100,914 | 1,438,491 |
| Interest expense | (301,147) | ||||
| Other income | 56,047 | ||||
| Unrealized (loss) gain on fair value of warrants | (1,195,932) | 1,866,249 | (655,545) | 1,993,469 | 3,020,560 |
| Unrealized gain on fair value of put feature on common stock | 2,315,539 | ||||
| Financing expense | (97,667) | (640,023) | |||
| Beneficial conversion feature | (1,625,000) | ||||
| Total Other Income (Expense) | (1,189,291) | 1,885,841 | (638,361) | 1,992,756 | 4,251,166 |
| Net Loss Before Provision for Income Taxes | (2,989,070) | (1,469,218) | (6,171,266) | (11,734,231) | (63,255,879) |
| Net Loss | $ (2,989,070) | $ (1,469,218) | $ (6,171,266) | $ (11,734,231) | $ (63,255,879) |
| Loss per share, basic and diluted | $ (0.03) | $ (0.02) | $ (0.06) | $ (0.13) | |
| Weighted average number of shares outstanding, basic and diluted | 95,345,656 | 95,240,221 | 95,345,656 | 92,276,111 | |
| X | ||||||||||
|
- Definition
Changes in the fair value of the anti-dilution make-whole provision (valued using a probability-weighting of put values provided by the Lattice model) of the put feature on common stock. No definition available.
|
| X | ||||||||||
|
- Definition
The net change during the reporting period in the fair value of warrant liabilities. No definition available.
|
| X | ||||||||||
|
- Definition
Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Represents the charge against earnings during the period for commitment fees and debt issuance expenses. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. No definition available.
|
| X | ||||||||||
|
- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Interest expense on all other items not previously classified. For example, includes dividends associated with redeemable preferred stock of a subsidiary that is treated as a liability in the parent's consolidated balance sheet. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Income derived from investments in debt securities and on cash and cash equivalents the earnings of which reflect the time value of money or transactions in which the payments are for the use or forbearance of money. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Costs incurred and are directly related to generating license revenue. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents the total realized gain (loss) included in earnings for the period as a result of selling marketable securities categorized as trading, available-for-sale, or held-to-maturity. Additionally, this item would include any losses recognized for other than temporary impairments (OTTI) of the subject investments in debt and equity securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
|
- Definition
The aggregate amount of other income amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) profits on securities (net of losses), and (d) miscellaneous other income items. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). No definition available.
|